$CPXX..$2.40 Q4. Cash $34M CPX-351 Phase 3 study: 2Q 2015 – Induction response rate 1Q 2016 – OS data http://finance.yahoo.com/news/celator-pharmaceuticals-announces-business-fourth-200100625.html?soc_src=mediacontentstory&soc_trk=tw … (h/t@biostocks)